Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

Regeneron and Sanofi Announced Dupixent Late-Breaking Phase 3 Data Presented at UEG Week 2022 Showed Significant Histological Remission of Eosinophilic Esophagitis in Children 1 to 11

By Charles Gross
October 11, 4:52 AM
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today presented late-breaking positive results from a Phase 3 trial evaluating the investigational use of Dupixent® (dupilumab) in children aged 1 to 11 years with active eosinophilic esophagitis (EoE).

REGN

Read More
2 minute read

Castle Biosciences To Present Data Supporting The Clinical Value Of Its Suite Of Skin Cancer Tests Through Multiple Oral Presentations At The 2022 American Society For Dermatologic Surgery Annual Meeting

By Benzinga Newsdesk
October 10, 7:06 AM
Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, is presenting data highlighting its portfolio of skin cancer gene expression profile (GEP) tests at the

CSTL

Read More
2 minute read

These 2 Mortgage REITs Have Yields Higher Than 15% And Are Trading Below Book Value

By Robert Kuczmarski
October 9, 10:06 AM
When investing in mortgage real estate investment trusts, one advantage investors should know about is that they typically have higher yields than equity REITs, and should never trade at a premium to their book value more than the dividend yield.

MITT